COVID-19 Coagulopathy: Whom to Anticoagulate and How? What Agents to…

Rush University Medical Center

S. Jain

CTEPH - Chronic Thromboembolic Pulmonary Hypertension Thoughts on Di…

Mitral Foundation

R. Martin, A. Anyanwu

VTE Prophylaxis After THA: Chinese Experience

Arthroplasty Society in Asia

H. Cai

VTE Prophylaxis After THA for Asian Population: Pharmacological Prop…

Arthroplasty Society in Asia

M. Mihara

VTE Prophylaxis After THA in the Asians: Messages from 2019 AP VTE C…

Arthroplasty Society in Asia

A. Tanavalee

New European Guidelines on Pulmonary Embolism: What Has Changed and …

PERT Consortium 2021

S. Konstantinides

Cancer-Associated Thrombosis: Defining, Risk Assessment, and Prognos…

BMFcases

T. Bat, M. Carrier

Pulmonary Hypertension: The Basic Essential Facts

Mount Sinai Advanced Heart Disease Symposium 2017

M. Trivieri

How do I Recognize and Treat the VEXAS Syndrome?

Cleveland Clinic Rheumatology

P. Grayson

Classification, Diagnosis and Management of Pulmonary Hypertension: …

Icahn School of Medicine at Mount Sinai

R. Benza

Interstitial Lung Disease in Rheumatic Diseases

University of Colorado Department of Medicine

M. Griffith

Acute DVT: When to and When Not to Intervene?

Venous Edge

S. Elias, C. Pena, C. Huff, R. Winokur, K. BROWN

CardioPulmonary Exercise Test (CPET) Interpretation for Non-Experts

National Jewish Health

L. A Manka

Prevention and Treatment of Cancer-Associated Thrombosis: What Are t…

James Douketis

Pulmonary Embolism: Where Are We in 2024?

UPMC

B. Rivera-Lebron

Pulmonary Hypertension Due to Lung Disease / Chronic Pulmonary Embol…

Scripps Health

K. Fan

PE - The Great Masquerader: A Disease of Many Faces: Cases Where I W…

Pulmonary Embolism 2016

V. Tapson

Management of Acute Pulmonary Embolism: How Long Do You Treat?

NYU Langone

N. Amoroso

Medical Management of CTEPH

Northwestern Medicine: 3rd Annual Advances in Pulmonary Hypertension

J. Rich

Thrombus Extending into the IVC

Venous Symposium

P. Muck